A Study of Imvotamab in Severe Systemic Lupus Erythematosus
Clinical trial NCT06041568 · TERMINATED
Trial details
- NCT number
- NCT06041568
- Sponsor
- IGM Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2025-01-27
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.